CD4+ and CD8+ T cells are essential components of tumor immunity, with CD4+ T cells enhancing immune responses and promoting CD8+ T‐cell activation, while CD8+ T cells directly kill tumor cells.32 This evidence concerns the gene CD8A and neoplasm.